Header cover image
  • Investing Ideas
  • South African Pharmaceuticals & Biotech Undervalued over 20% based on DCF

South African Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Aspen Pharmacare Holdings

Market Cap: R65.9b

Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.

APN

R150.17

7D

2.1%

1Y

32.2%